December 18, 2020
Three days into a virtual bench trial in Delaware federal court, Bayer AG and MSN Laboratories on Friday proposed to end their legal fight over MSN's plans to market a generic version of one of Bayer's bestselling drugs, the high blood pressure medication Adempas.
November 30, 2020
Bayer is going to court again to stop a rival from coming out with a generic version of one of its bestselling drugs, a high blood pressure medication called Adempas.